Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 4861 AL 4875

Orthostatic Hypotension and Antiparkinsonian Drugs: A Systematic Review and Meta-analysis

Nimmons D, Bhanu C, Orlu M, Schrag A, Walters K.

J Geriatr Psychiatry Neurol. 2022 Sep;35(5):639-654. doi: 10.1177/08919887211060017. Epub 2021 Dec 29.

Targeting PKC in microglia to promote remyelination and repair in the CNS

Kim PM, Kornberg MD.

Curr Opin Pharmacol. 2022 Feb;62:103-108. doi: 10.1016/j.coph.2021.11.008. Epub 2021 Dec 26.

Graphene-based Nanomaterials in Fighting the Most Challenging Viruses and Immunogenic Disorders

Ebrahimi M, Asadi M, Akhavan O.

ACS Biomater Sci Eng. 2022 Jan 10;8(1):54-81. doi: 10.1021/acsbiomaterials.1c01184. Epub 2021 Dec 30.

Dural Arteriovenous Fistula-Derived Parkinsonism Symptoms: A Case Report with Literature Review

Tominaga A, Kiura Y, Kondo H, Takeshita S, Magaki T, Sakoguchi T, Maeda Y, Takeishi Y, Tsuyuguchi S, Shiota D.

J Neuroendovasc Ther. 2022;16(5):257-264. doi: 10.5797/jnet.cr.2021-0069. Epub 2021 Aug 25.

Roles of clock genes in the pathogenesis of Parkinson's disease

Shkodina AD, Tan SC, Hasan MM, Abdelgawad M, Chopra H, Bilal M, Boiko DI, Tarianyk KA, Alexiou A.

Ageing Res Rev. 2022 Feb;74:101554. doi: 10.1016/j.arr.2021.101554. Epub 2021 Dec 30.

Possible association between PM(2.5) and neurodegenerative diseases: A systematic review

Cristaldi A, Fiore M, Oliveri Conti G, Pulvirenti E, Favara C, Grasso A, Copat C, Ferrante M.

Environ Res. 2022 May 15;208:112581. doi: 10.1016/j.envres.2021.112581. Epub 2021 Dec 31.

Primary cilia and ciliary signaling pathways in aging and age-related brain disorders

Ma R, Kutchy NA, Chen L, Meigs DD, Hu G.

Neurobiol Dis. 2022 Feb;163:105607. doi: 10.1016/j.nbd.2021.105607. Epub 2021 Dec 31.

Invited Perspective on "Apathy as a Within-Person Mediator of Depressive Symptoms and Cognition in Parkinson's Disease: Longitudinal Mediation Analyses"

Hinkle JT, Pontone GM.

Am J Geriatr Psychiatry. 2022 Jun;30(6):675-677. doi: 10.1016/j.jagp.2021.12.004. Epub 2021 Dec 9.

Histone deacetylase 6 inhibitors with blood-brain barrier penetration as a potential strategy for CNS-Disorders therapy

Gu X, Zhang H, Jiao M, Han B, Zhang Z, Li J, Zhang Q.

Eur J Med Chem. 2022 Feb 5;229:114090. doi: 10.1016/j.ejmech.2021.114090. Epub 2021 Dec 29.

A multimodal Parkinson quantification by fusing eye and gait motion patterns, using covariance descriptors, from non-invasive computer vision

Archila J, Manzanera A, Martínez F.

Comput Methods Programs Biomed. 2022 Mar;215:106607. doi: 10.1016/j.cmpb.2021.106607. Epub 2021 Dec 30.

Characteristics of wearing-off and motor symptoms improved by safinamide adjunct therapy in patients with Parkinson's disease: A post hoc analysis of a Japanese phase 2/3 study

Nomoto M, Ishida T, Koebis M, Kamei T, Suzuki I, Hattori N, Tsuboi Y.

J Neurol Sci. 2022 Mar 15;434:120083. doi: 10.1016/j.jns.2021.120083. Epub 2021 Dec 11.

Ganglioside binding domains in proteins: Physiological and pathological mechanisms

Azzaz F, Yahi N, Di Scala C, Chahinian H, Fantini J.

Adv Protein Chem Struct Biol. 2022;128:289-324. doi: 10.1016/bs.apcsb.2021.08.003. Epub 2021 Oct 11.

Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia

Ni R, Nitsch RM.

Front Aging Neurosci. 2022 Jan 3;13:751897. doi: 10.3389/fnagi.2021.751897. eCollection 2021.

Retrotransposons as a Source of DNA Damage in Neurodegeneration

Peze-Heidsieck E, Bonnifet T, Znaidi R, Ravel-Godreuil C, Massiani-Beaudoin O, Joshi RL, Fuchs J.

Front Aging Neurosci. 2022 Jan 4;13:786897. doi: 10.3389/fnagi.2021.786897. eCollection 2021.

Impact of fatty acid-binding proteins and dopamine receptors on α-synucleinopathy

Kawahata I, Fukunaga K.

J Pharmacol Sci. 2022 Feb;148(2):248-254. doi: 10.1016/j.jphs.2021.12.003. Epub 2021 Dec 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias